United States · Health Care startup
United States · Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Funding reportedLast round: Post ipo equity
What company datasets say Viking Therapeutics raised
Funding, as reported
Reported in all$1.1Bin dollars
Rounds7
Last roundPost ipo equity
Last round dateFeb 2024
Investors listed2
Founders and team
From Viking Therapeutics's own website: 4 on the team.
- Kenneth J. HermanSenior Vice President, Commercial, Marketing and Sales
- Michael MorneauVice President, Finance and Administration
- Tavette NeskorikVice President, Clinical Operations
- Greg ZanteChief Financial Officer
On a portfolio page
Investors who name them
Each firm lists Viking Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Health Care in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Viking Therapeutics in front of investors. Or tell us what we have wrong.